OncoSec Medical Inc. (ONCS) Starts Presentation at LD Micro Conference

OncoSec Medical Inc. is a biopharmaceutical company developing investigational ImmunoPulse intratumoral cancer immunotherapy. The company’s primary technology is designed to enhance the local delivery and uptake of DNA IL-12 and other DNA-based immune-targeting agents. Clinical studies of ImmunoPulse have demonstrated an acceptable safety profile and preliminary evidence of anti-tumor activity in the treatment of various skin cancers.  For more information, visit the company’s Web site at www.oncosec.com.